CellMax Life logo.png
CellMax Life Earns FDA Breakthrough Device Designation for Colon Cancer & Pre-Cancerous Adenomas Screening Blood Test
August 25, 2021 06:00 ET | CellMax Life
SUNNYVALE, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- CellMax Life, a molecular diagnostics company, announced today that its FirstSight™ pre-cancer and cancer detection blood test has received...
Forecast Report [2020-2026], Colorectal Cancer Screening Market Size, Share, Growth, Trends, Revenue, Analysis, Competitive Landscape by Fortune Business Insights
October 07, 2020 09:01 ET | Fortune Business Insights
Pune, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The stool-based test segment is expected to acquire a significant percentage of global colorectal cancer screening market share during the forecast period....
World Market Outlook for the Anatomic Pathology Market to 2025 - Global Anatomic Pathology Market to Register a CAGR of 7.1% Between 2020 and 2025
August 26, 2020 04:27 ET | Research and Markets
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application...
In-Vitro Colorectal Cancer Screening Tests Market worth $900mn by 2023: Global Market Insights Inc.
February 02, 2017 06:30 ET | Global Market Insights
Ocean View, Delaware, Feb. 02, 2017 (GLOBE NEWSWIRE) -- The report “In-Vitro Colorectal Cancer Screening Tests Market Size By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB...